The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multimodality therapy including surgical resection (SR) and intraoperative electron radiotherapy (IOERT) for locoregionally recurrent (LRR) or advanced primary malignancies of the urinary bladder (UB) or ureter.
Christopher Leigh Hallemeier
No relevant relationships to disclose
R. Jeffrey Karnes
No relevant relationships to disclose
Thomas Michael Pisansky
No relevant relationships to disclose
Brian Davis
No relevant relationships to disclose
Leonard L. Gunderson
No relevant relationships to disclose
Bradley C. Leibovich
No relevant relationships to disclose
Michael G. Haddock
No relevant relationships to disclose
Richard Choo
No relevant relationships to disclose